And What About The Science?


If President Bush hoped that his decision last week to permit limited federal funding of embryonic stem-cell research would quiet the ferocious debate surrounding the issue, it was a hope that was quickly dashed. Since his announcement, advocates on both sides have continued to find plenty to argue about--whether there are really 60 existing cell lines on which the President would allow research; whether those lines would be sufficient to yield real results; whether the restrictive rules will simply drive U.S. stem-cell researchers to other countries where they can do their work with less government interference.

But nearly everyone agrees on...

Want the full story?

Subscribe Now


Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!